SkyAI, Inc.

NASDAQ:STSS

Medical - Instruments & Supplies

Healthcare
$1.32 +0.00%

+$0.00 today

Market cap
$55.65M
Beta
2.02
P/E (TTM)
1.3
EPS (TTM)
$0.91
52W Low $1.09High $18.23

Volume 0.00M

Average 0.37M

STSS Interest Expense

Cost of servicing the company's debt during the period.

SkyAI, Inc.NASDAQ: STSS

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense remains negative

Q1 FY2026 interest expense was $0, compared with $0 a year earlier. Trailing-twelve-month interest expense was $120.55K. Over 3 fiscal years it compounded at -31.9% a year.

Context

  • Interest expense amounted to 204.1% of revenue in FY2025.
  • Interest expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly interest expense holds near $0 or moves back toward the trailing-twelve-month quarterly average of $30.14K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$416.66K-75.6% YoY
LTMMar 2026
$120.55K— YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-75.6%——
3-year CAGR-31.9%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
416.66K USD
Year-over-year change
-75.6%
4-year CAGR
+25.6%

Interest Expense vs competitors

How STSS compares with its peers on the latest reported figures

  • STSS's LTM Mar 2026 interest expense of $120.55K is the 4th highest of the 10 companies compared; the peer median is $13K.
  • Interest expense amounts to 30.4% of revenue for STSS, versus a peer median of 0.4%.
STSS Competitors Peer median
Interest Expense for STSS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$1.87M ——5.4%
PDEXPro-Dex, Inc.LTM Mar 2026$769K +2.4%+21.3%1.0%
CCLDCareCloud, Inc.LTM Mar 2026$287K -51.6%-10.8%0.2%
STSSSkyAI, Inc.LTM Mar 2026$120.55K —-31.9%30.4%
LUCDLucid Diagnostics Inc.LTM Mar 2026$20K -13.0%+40.1%0.4%
CGTXCognition Therapeutics, Inc.LTM Mar 2026$13K -35.0%-22.6%—
SERASera Prognostics, Inc.LTM Mar 2026$7K -69.6%-47.2%12.3%
GLSIGreenwich LifeSciences, Inc.LTM Mar 2026$0 ———
JYNTThe Joint Corp.LTM Mar 2026$0 ——0.0%
MBOTMicrobot Medical Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding STSS) $13K-35.0%-10.8%0.4%

Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000204.12K
Cost of Revenue28.7K654.57K891.25K773.9K617.45K
Gross Profit(28.7K)(654.57K)(891.25K)(773.9K)(413.33K)
Gross Margin————-202.5%
Research & Development1.69M1.63M729.48K(58.03K)198.76K
Selling, General & Admin2.78M6.45M8.52M7.14M19.49M
Operating Expenses4.47M8.08M9.24M7.08M12.88M
Depreciation & Amortization28.7K654.57K891.25K773.9K132.54K
EBITDA(4.47M)(2.66M)(8.98M)(6.85M)(269.74M)
EBITDA Margin————-132145.5%
Operating Income(4.5M)(8.74M)(10.13M)(7.86M)(13.29M)
Operating Margin————-6512.1%
Interest Income7691.32K138.12K40.3K0
Interest Expense167.52K1.32M01.71M416.66K
Other Income / Expenses(166.75K)4.1M255.01K(1.47M)(257.04M)
Income Before Tax(4.66M)(4.64M)(9.87M)(9.33M)(270.34M)
Pre-Tax Margin————-132439.5%
Income Tax Expense00(30K)(30K)0
Net Income(4.66M)(4.64M)(9.84M)(9.3M)(282.5M)
Net Margin————-138400.0%
EPS (Basic)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
EPS (Diluted)(3,356.30)(3,780.28)(4,983.99)(2,220.05)(11.16)
Weighted Avg Shares1.39K1.23K1.97K4.19K25.31M
Weighted Avg Shares (Diluted)1.39K1.23K1.97K4.19K25.31M

SkyAI, Inc.

NASDAQ:STSS

Intrinsic Alpha fair value

Locked

Current Price

$1.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.